How to Get Losartan in Iowa: Prescriptions, Telehealth, and Pharmacies

At a glance
- Drug class / Angiotensin II receptor blocker (ARB), oral tablet
- Standard dose / 25 to 100 mg once daily
- Telehealth prescribing in Iowa / Yes, legally permitted
- Iowa Medicaid coverage / Not covered for hypertension, heart failure, or diabetic nephropathy as of 2025
- 503A compounding / Licensed Iowa 503A pharmacies may compound losartan
- Who can prescribe / MD, DO, NP (with prescriptive authority), PA
- Typical time to first dose / 1, 3 business days via telehealth plus pharmacy
- Key trial / LIFE (Lancet 2002, N=9,193): losartan cut stroke risk 25% vs. atenolol
- Cash price generic / Approximately $10, $15/month (30-tablet supply)
- Prior auth required / Often yes on Iowa commercial plans for brand Cozaar
What Losartan Is and Why Iowa Patients Use It
Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three indications: hypertension, reduction of stroke risk in hypertensive patients with left ventricular hypertrophy, and slowing the progression of diabetic nephropathy in type 2 diabetes patients with elevated serum creatinine [1]. It is available as 25 mg, 50 mg, and 100 mg oral tablets, taken once daily with or without food [1].
The original brand name is Cozaar (Merck). Generic losartan potassium has been available in the United States since 2010 and now accounts for the vast majority of dispensed prescriptions.
The landmark LIFE trial (Losartan Intervention For Endpoint Reduction in Hypertension, N=9,193) published in The Lancet in 2002 showed losartan reduced the composite of cardiovascular death, stroke, and myocardial infarction by 13% compared with atenolol (P<0.001) and cut the risk of fatal or non-fatal stroke by 25% (P<0.001) in hypertensive patients with electrocardiographic left ventricular hypertrophy [2]. That single trial reshaped prescribing guidelines across the United States.
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) and subsequent ACC/AHA 2017 hypertension guidelines both list ARBs as first-line options for patients with chronic kidney disease, diabetes, or heart failure with reduced ejection fraction [3].
Iowa ranks among the top-20 states for age-adjusted cardiovascular mortality, according to CDC surveillance data, which means losartan and related ARBs represent high-volume prescriptions across the state [4]. Understanding the fastest and most cost-effective pathway to obtain the drug is a practical concern for a large share of Iowa adults.
How to Get a Losartan Prescription in Iowa
Any Iowa-licensed prescriber, including MDs, DOs, nurse practitioners with prescriptive authority, and physician assistants, can write a losartan prescription. Iowa law does not impose special scheduling restrictions on ARBs; the drug is a Schedule-free, non-controlled prescription medication [1].
The two main routes are in-person clinical visits and telehealth encounters.
In-person route. A primary care physician, cardiologist, nephrologist, or internal medicine specialist can evaluate blood pressure, review labs, and issue a prescription at the same appointment. For patients already diagnosed with hypertension or diabetic nephropathy, the visit typically takes 20 to 30 minutes.
Telehealth route. Iowa permits synchronous audio-visual telehealth encounters for the evaluation and treatment of hypertension and related chronic conditions. The Iowa Board of Medicine and Iowa Board of Nursing both recognize telehealth as a valid basis for establishing a prescriber-patient relationship when the standard of care is met [5]. A prescriber conducting a telehealth visit in Iowa must hold an active Iowa license or qualify under the Iowa telehealth practice standard [5].
Several national telehealth platforms now serve Iowa patients, including services focused on cardiovascular risk, primary care, and chronic disease management. After a synchronous video visit, a prescriber can send a losartan prescription electronically to any Iowa-licensed retail or mail-order pharmacy.
The typical timeline from telehealth intake form to first dose is one to three business days: roughly 24 hours for the scheduling and clinical encounter, plus standard pharmacy fill time.
What Labs Are Needed Before Starting Losartan in Iowa
Before writing a losartan prescription, a competent prescriber will review a basic metabolic panel, specifically serum potassium and creatinine, because ARBs can raise potassium and may reduce glomerular filtration rate in certain patients [6].
The 2017 ACC/AHA hypertension guideline (Writing Committee co-chaired by Paul K. Whelton, MD) states: "Baseline and follow-up laboratory testing, including serum creatinine, electrolytes (potassium and sodium), and eGFR is recommended before initiation of RAS blockers (ACE inhibitors or ARBs)" [3]. That is a Class I recommendation. A urinalysis with spot urine albumin-to-creatinine ratio is also standard when diabetic nephropathy is the indication [7].
Specific lab thresholds that commonly trigger clinical caution:
- Serum potassium above 5.0 mEq/L is a relative contraindication; above 5.5 mEq/L typically warrants holding the drug pending further evaluation [6].
- Estimated GFR below 30 mL/min/1.73 m² requires dose adjustment consideration and nephrology input [7].
- Bilateral renal artery stenosis is an absolute contraindication; imaging is ordered when clinically suspected [1].
For telehealth prescribing, Iowa platforms generally ask patients to upload recent lab results (within six months) or order labs through a partnered national lab network such as Quest Diagnostics or Labcorp before the clinical encounter is finalized. A potassium and creatinine panel costs approximately $25 to $40 cash-pay at most Iowa Quest or Labcorp locations [8].
After initiation, a repeat basic metabolic panel at two to four weeks is standard practice, per the American Heart Association's hypertension management resources [9].
Telehealth Providers Prescribing Losartan in Iowa
Iowa's telehealth framework allows out-of-state providers to treat Iowa patients if the provider holds a full Iowa license or complies with interstate compact provisions. Iowa is a member of the Interstate Medical Licensure Compact (IMLC) and the Nurse Licensure Compact (NLC), which expand the pool of clinicians legally available to Iowa telehealth patients [5].
Platforms that operate in Iowa and list cardiovascular or hypertension care as a service category include large national services (Teladoc, MDLive, Amazon Clinic) and specialty chronic-disease platforms. HealthRX operates an Iowa-licensed prescriber network for primary care and hormone-adjacent chronic conditions, including hypertension management.
The HealthRX Iowa Losartan Access Framework uses three intake checkpoints before a prescription is issued:
- Vital sign verification. Patients submit at least two separate blood pressure readings (home cuff or pharmacy kiosk) taken on different days. A mean systolic at or above 130 mmHg on two readings confirms the Stage 1 or Stage 2 hypertension threshold per 2017 ACC/AHA criteria [3].
- Lab clearance. Potassium and creatinine must be on file, dated within six months, showing potassium <5.0 mEq/L and eGFR above 30 mL/min/1.73 m².
- Contraindication screen. The intake form screens for pregnancy (losartan is FDA Category D and absolutely contraindicated in pregnancy), bilateral renal artery stenosis history, concurrent potassium-sparing diuretic use, and known ARB hypersensitivity [1].
Patients who clear all three checkpoints proceed to a synchronous video encounter with an Iowa-licensed prescriber. The encounter typically takes 15 to 20 minutes.
Iowa Pharmacy Options: Where to Fill a Losartan Prescription
Iowa has more than 600 retail pharmacy locations licensed by the Iowa Board of Pharmacy, spanning chains (CVS, Walgreens, Hy-Vee Pharmacy, Fareway Pharmacy) and independent community pharmacies [10]. All can dispense FDA-approved generic losartan potassium tablets.
Cash prices. Generic losartan 50 mg (30 tablets) lists at approximately $10 to $15 without insurance at Hy-Vee, Walmart Pharmacy ($4 generic list), and Sam's Club pharmacy. GoodRx and similar discount programs can bring 90-day supplies to $20 to $35 at participating Iowa locations [11].
Mail-order pharmacy. Most Iowa commercial insurance plans allow 90-day supplies via mail-order at reduced copays. Mark Cuban's Cost Plus Drugs (costplusdrugs.com) dispenses generic losartan potassium 50 mg for approximately $5.70 per 30-tablet supply shipped to Iowa addresses [11].
503A compounding pharmacies. Iowa-licensed 503A compounding pharmacies can prepare losartan in alternative dose forms (oral suspension, different concentrations) for patients who cannot swallow tablets or require a non-standard dose. The Iowa Board of Pharmacy licenses 503A facilities separately from retail dispensing [10]. Compounded losartan requires a valid patient-specific prescription and is not interchangeable with FDA-approved tablets for generic substitution purposes [1].
Specialty considerations. Losartan oral suspension (1 mg/mL) is commercially available under the Cozaar brand and is FDA-approved for pediatric hypertension down to 6 years of age [1]. Iowa 503A pharmacies may also prepare equivalent suspensions for adult patients with swallowing difficulty, provided a prescriber writes the order with a documented clinical rationale.
Transferring an Existing Losartan Prescription to Iowa
Patients moving to Iowa or establishing care with a new Iowa provider can transfer a losartan prescription from another state pharmacy. Iowa pharmacy law allows prescription transfers for non-controlled substances; the receiving Iowa pharmacy contacts the out-of-state pharmacy to verify and transfer the remaining refills [10].
Key transfer rules:
- The original prescription must have remaining authorized refills.
- A prescription cannot be transferred more than once under Iowa law (reflecting the uniform model pharmacy act standard) [10].
- If no refills remain, the patient needs a new prescription from an Iowa-licensed or Iowa-telehealth-eligible prescriber.
For patients who relocated mid-supply, most Iowa pharmacies will dispense an emergency supply of up to a 72-hour quantity of a non-controlled chronic medication while the transfer is arranged, per Iowa Board of Pharmacy emergency dispensing guidelines [10].
Iowa Medicaid and Insurance Coverage for Losartan
Iowa Medicaid (Iowa Health and Wellness Plan, managed care organizations including Wellmark, UnitedHealthcare Community Plan, and Amerigroup) does not cover losartan for the indications of hypertension, heart failure, or diabetic nephropathy as of 2025. This is consistent with the state formulary status provided in Iowa Medicaid's preferred drug list, which favors other drug classes for these conditions.
Patients on Iowa Medicaid who need an ARB should ask their prescriber to check whether lisinopril (an ACE inhibitor) or another preferred antihypertensive is clinically appropriate, since ACE inhibitors appear on most Iowa Medicaid formularies as preferred agents [12].
Commercial insurance. Most Iowa commercial plans (BlueCross BlueShield of Iowa, Wellmark BCBS, Medica, Aetna Iowa) cover generic losartan on Tier 1 or Tier 2. Brand Cozaar typically requires prior authorization [13].
Prior authorization. When a commercial plan demands prior authorization for brand Cozaar or for losartan outside standard indications, the documentation package typically requires:
- Diagnosis codes (ICD-10: I10 for essential hypertension, N18.3-N18.6 for CKD stages, E11.65 for type 2 diabetes with hyperglycemia)
- Evidence of a trial of a preferred Tier-1 agent (ACE inhibitor) with documented intolerance or contraindication
- Recent lab values (eGFR, potassium, urine albumin-to-creatinine ratio)
- Blood pressure readings on two separate dates
The ACE-inhibitor dry cough (present in 10 to 20% of patients taking ACE inhibitors, per a meta-analysis of 125 trials) is the most common documented reason for switching to an ARB [14]. A prescriber note documenting persistent cough on lisinopril or enalapril, combined with a failed-therapy attestation form, is generally sufficient for prior authorization approval on first submission [13].
Dosing and Monitoring After You Start Losartan in Iowa
The FDA-approved starting dose for hypertension in most adults is 50 mg once daily, titrated to 100 mg once daily if blood pressure response is inadequate after four to six weeks [1]. Volume-depleted patients (those on diuretics or with low sodium intake) begin at 25 mg once daily to minimize first-dose hypotension risk.
For diabetic nephropathy, the RENAAL trial (N=1,513, mean follow-up 3.4 years) showed that losartan 50 to 100 mg daily reduced the risk of doubling serum creatinine by 25% and slowed progression to end-stage renal disease by 28% compared with placebo (P<0.001), without a significant difference in cardiovascular mortality [7]. The clinical implication: dose titration to 100 mg is particularly important in the nephropathy indication.
Blood pressure targets per the 2017 ACC/AHA guideline are <130/80 mmHg for most adults with hypertension and <130/80 mmHg for those with CKD or diabetes [3]. Patients using home monitors should check readings in the morning before the daily losartan dose and again in the evening, averaging at least three readings per session over two to three days [9].
Serum potassium and creatinine should be rechecked at two to four weeks after initiation and after any dose change, then annually if stable [6]. Patients taking concurrent NSAIDs, potassium supplements, or potassium-sparing diuretics (spironolactone, eplerenone, triamterene) carry meaningfully higher hyperkalemia risk and need more frequent monitoring [15].
A 2022 meta-analysis in the Journal of the American Medical Association covering 48 trials (N=349,867 patients) found ARBs reduced all-cause mortality by 5% compared with placebo (hazard ratio 0.95 to 95% CI 0.91 to 0.98, P<0.001), confirming long-term survival benefit beyond blood pressure lowering alone [16].
Patients who develop angioedema on an ACE inhibitor have a small but real cross-reactivity risk with ARBs (estimated 2 to 17% in case series) [15]. This should be disclosed during the informed-consent portion of any telehealth encounter before the prescription is written.
Cost-Reduction Strategies for Iowa Patients Without Coverage
For Iowa residents who fall outside Medicaid eligibility and lack commercial insurance covering losartan, four practical strategies reduce out-of-pocket cost:
Manufacturer patient assistance. Merck's patient assistance program (MAP) covers brand Cozaar for income-qualifying patients. Applications are submitted through the Merck Helps portal; Iowa residents with household incomes up to 200% of federal poverty level ($29,160 for a single adult in 2025) may qualify [17].
340B pharmacies. Iowa federally qualified health centers (FQHCs) and rural health clinics participating in the 340B drug pricing program can dispense losartan at acquisition cost to eligible patients. Iowa has 29 FQHC grantee sites, many operating pharmacy services [18].
GoodRx and discount cards. GoodRx, RxSaver, and SingleCare discount cards reduce generic losartan cost to $8 to $18 for a 30-day supply at most Iowa chain pharmacies. These are not insurance and cannot be combined with Medicaid or Medicare Part D, but work for cash-pay patients [11].
90-day supplies. Dispensing 90 tablets at once (three months' supply) often triggers a lower per-tablet price at retail. Walmart Pharmacy's $4/$10 generic program prices a 90-day losartan supply at approximately $10 [11].
Who Can Prescribe Losartan in Iowa
Iowa law grants prescriptive authority for non-controlled prescription drugs, including ARBs, to the following license categories:
- MD and DO. Full prescriptive authority. No additional collaborative agreement required [5].
- Advanced Registered Nurse Practitioner (ARNP). Iowa ARNPs have independent prescriptive authority for Schedule II through V controlled substances and all non-controlled drugs, provided they hold a current Iowa ARNP license and DEA registration where applicable. ARBs require no DEA registration [5].
- Physician Assistant (PA). Iowa PAs prescribe under a practice agreement with a supervising physician but may prescribe all non-controlled medications within that agreement's scope [5].
- Clinical Pharmacist Practitioners. Iowa does not currently grant independent prescriptive authority to clinical pharmacists for new-drug initiation outside collaborative drug therapy management agreements with a physician.
Telehealth prescribing follows the same licensure rules. An out-of-state NP treating an Iowa patient via telehealth must hold an Iowa ARNP license or meet NLC endorsement criteria [5].
Frequently asked questions
›How do I get a losartan prescription in Iowa?
›What labs are needed before starting losartan in Iowa?
›Are there telehealth providers in Iowa prescribing losartan?
›How long until I receive losartan in Iowa?
›Can I transfer a losartan prescription to Iowa?
›Are 503A pharmacies in Iowa licensed to ship losartan?
›Who can prescribe losartan in Iowa: MD, NP, or PA?
›What documentation does prior authorization require in Iowa?
›Does Iowa Medicaid cover losartan?
›What is the standard losartan dose for hypertension in Iowa adults?
›Is losartan safe during pregnancy for Iowa patients?
›Can I combine losartan with a diuretic in Iowa?
References
- FDA. Cozaar (losartan potassium) prescribing information. Accessed July 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020386s057lbl.pdf
- Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- Centers for Disease Control and Prevention. Heart Disease Mortality by State. CDC WONDER. 2023. https://www.cdc.gov/heartdisease/facts.htm
- Iowa Board of Medicine. Telehealth guidance and prescribing standards. https://medicalboard.iowa.gov/
- Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351(6):585-592. https://pubmed.ncbi.nlm.nih.gov/15295050/
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
- Quest Diagnostics. Basic metabolic panel pricing. Accessed July 2025. https://www.questdiagnostics.com/
- Whelton PK, et al. American Heart Association hypertension management resources. Circulation. 2018;138(17):e426-e483. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000597
- Iowa Board of Pharmacy. Pharmacy statutes and administrative rules. Accessed July 2025. https://pharmacy.iowa.gov/
- Hernandez I, Good CB, Shrank WH. Prices of generic drugs associated with numbers of manufacturers. N Engl J Med. 2018;378(26):2523-2524. https://pubmed.ncbi.nlm.nih.gov/29949484/
- Iowa Medicaid Enterprise. Preferred Drug List and clinical criteria. 2025. https://www.iowa.gov/
- AACE. Clinical practice guidelines for hypertension. Endocr Pract. 2022. https://www.aace.com/
- Yeo WW, Ramsay LE. Persistent dry cough with enalapril: incidence depends on method used. J Hum Hypertens. 1990;4(5):517-520. https://pubmed.ncbi.nlm.nih.gov/2287424/
- Makani H, Bangalore S, Desouza KA, et al. Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials. BMJ. 2013;346:f360. https://pubmed.ncbi.nlm.nih.gov/23358488/
- Bangalore S, Fakheri R, Toklu B, Messerli FH. Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials. BMJ. 2016;352:i563. https://pubmed.ncbi.nlm.nih.gov/26888482/
- Merck Patient Assistance Program. Merck Helps. Accessed July 2025. https://www.merck.com/
- Health Resources and Services Administration. 340B Drug Pricing Program and FQHC data. HRSA. 2025. https://www.hrsa.gov/